Chronic hand eczema (CHE) is a long-lasting skin condition characterized by redness, scaling, cracking, itching, and sometimes painful fissures on the hands. It often develops due to a combination of genetic predisposition, environmental exposure, irritants, and allergens, making it both complex and challenging to manage.
For many patients, standard treatments such as topical corticosteroids or moisturizers may not provide sufficient or lasting relief. This is where clinical research plays a critical role. At Rejuvenation Dermatology, our chronic hand eczema clinical trials are designed to evaluate innovative therapies that target the underlying causes of inflammation and skin barrier dysfunction.
Participants in our trials receive access to investigational treatments in a controlled, medically supervised environment. Each study follows strict regulatory and ethical guidelines, ensuring patient safety while contributing to the advancement of dermatologic care.
Our goal is not only to improve symptoms such as itching, dryness, and pain, but also to enhance quality of life by restoring skin function and reducing flare-ups over time.
EVIDENCE DRIVES BETTER ECZEMA CARE
We believe chronic hand eczema treatment should be guided by rigorous clinical evidence, not temporary symptom control. Our clinical trials are designed to evaluate advanced therapies that target inflammation and skin barrier repair, generating meaningful data that helps improve long-term patient outcomes.
RESEARCH INTEGRATED INTO REAL CLINICAL PRACTICE
All studies are conducted within active dermatology clinics, allowing patients to receive care in a familiar and professional setting. Our dermatologists understand the functional and occupational impact of chronic hand eczema, ensuring treatment approaches consider both medical and lifestyle factors.
ETHICS ARE NON-NEGOTIABLE
Every chronic hand eczema trial undergoes independent ethics board review before enrollment begins. Participants are fully informed, carefully screened, and continuously monitored throughout the study, with safety protocols that meet and exceed regulatory standards.
STANDARDIZED, NATIONAL EXECUTION
Our multi-site research network operates under centralized oversight and standardized protocols. This ensures consistency in data collection, high-quality study execution, and reliable outcomes across all participating locations.
Clinical research at Rejuvenation Dermatology is driven by a commitment to advance patient care through evidence-based medicine. Through participating in regulated clinical trials, the organization helps to shape development of safer, more effective dermatologic treatments while ensuring patients receive care that meets the highest ethical and scientific standards.
Participation in clinical research enables Rejuvenation physicians to remain at the forefront of dermatologic innovation and provides patients with access to therapies that may not yet be commercially available.
DERMATOLOGY-LED RESEARCH
Our trials are led by experienced dermatologists who specialize in inflammatory skin conditions. With physician oversight at every stage, patients receive care that is both clinically precise and research-driven.
FOCUSED ON COMPLEX, REAL-WORLD CASES
Chronic hand eczema often involves multiple triggers and treatment challenges. Our studies are designed to reflect real-world patient needs, addressing cases that may not respond to standard therapies.
SAFETY FIRST, ALWAYS
Patient safety is central to every study we conduct. Strict eligibility criteria, ongoing monitoring, and adherence to Good Clinical Practice guidelines ensure participants are protected at every step.
CONSISTENT EXECUTION, TRUSTED RESULTS
Sponsors rely on our ability to recruit efficiently and deliver high-quality, audit-ready data. This structured approach ensures a smooth and reliable experience for participants.
ADVANCING FUTURE TREATMENTS
By participating in clinical trials, patients contribute to the development of new therapies that may shape the future of chronic hand eczema care, helping improve treatment options for others.
Chronic hand eczema is a long-term form of eczema that primarily affects the hands and tends to persist or recur over time.
Eligibility depends on the specific study, but generally includes individuals with moderate to severe or persistent hand eczema.
Yes, all treatments are carefully studied and monitored under strict medical and ethical guidelines.
CHRONIC HAND ECZEMA | CLINICAL TRIALS CANADA | REJUVENATION DERMATOLOGY
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
